Release Date: 13/07/12 11:43 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 164.59KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%